Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Oncogene ; 33(31): 4060-8, 2014 Jul 31.
Article in English | MEDLINE | ID: mdl-24166504

ABSTRACT

The glycolytic end-product lactate is a pleiotropic tumor growth-promoting factor. Its activities primarily depend on its uptake, a process facilitated by the lactate-proton symporter monocarboxylate transporter 1 (MCT1). Therefore, targeting the transporter or its chaperon protein CD147/basigin, itself involved in the aggressive malignant phenotype, is an attractive therapeutic option for cancer, but basic information is still lacking regarding the regulation of the expression, interaction and activities of both proteins. In this study, we found that glucose deprivation dose-dependently upregulates MCT1 and CD147 protein expression and their interaction in oxidative tumor cells. While this posttranslational induction could be recapitulated using glycolysis inhibition, hypoxia, oxidative phosphorylation (OXPHOS) inhibitor rotenone or hydrogen peroxide, it was blocked with alternative oxidative substrates and specific antioxidants, pointing out at a mitochondrial control. Indeed, we found that the stabilization of MCT1 and CD147 proteins upon glucose removal depends on mitochondrial impairment and the associated generation of reactive oxygen species. When glucose was a limited resource (a situation occurring naturally or during the treatment of many tumors), MCT1-CD147 heterocomplexes accumulated, including in cell protrusions of the plasma membrane. It endowed oxidative tumor cells with increased migratory capacities towards glucose. Migration increased in cells overexpressing MCT1 and CD147, but it was inhibited in glucose-starved cells provided with an alternative oxidative fuel, treated with an antioxidant, lacking MCT1 expression, or submitted to pharmacological MCT1 inhibition. While our study identifies the mitochondrion as a glucose sensor promoting tumor cell migration, MCT1 is also revealed as a transducer of this response, providing a new rationale for the use of MCT1 inhibitors in cancer.


Subject(s)
Basigin/metabolism , Cell Movement , Glucose/metabolism , Mitochondria/metabolism , Monocarboxylic Acid Transporters/metabolism , Reactive Oxygen Species/metabolism , Symporters/metabolism , Uterine Cervical Neoplasms/metabolism , Cell Line, Tumor , Female , Gene Expression Regulation, Neoplastic , Glycolysis/physiology , HeLa Cells , Humans , Mitochondria/genetics , Monocarboxylic Acid Transporters/genetics , Symporters/genetics
2.
Gait Posture ; 35(4): 647-52, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22257927

ABSTRACT

In order to achieve efficacious walking, transfemoral amputees must adapt coordination within both the artificial and the sound lower limb. We analyzed kinematic strategies in amputees using the planar covariation of lower limb segments approach. When the elevation angles of the thigh, shank and foot are plotted one versus the others, they describe a regular loop which lies close to a plane in normal adults' gait. Orientation of this plane changes with increased speed, in relation to mechanical energetic saving. We used an opto-electronic device to record the elevation angles of both limbs' segments of novice and expert transfemoral amputees and compared them to those of control subjects. The statistical structure underlying the distribution of these angles was described by principal component analysis and Fourier transform. The typical elliptic loop was preserved in prosthetic walking, in both limbs in both novice and expert transfemoral amputees. This reflects a specific control over the thigh elevation angle taking into account knowledge of the other elevation angles throughout the gait cycle. The best-fitting plane of faster trials rotates around the long axis of the gait loop with respect to the plane of slower trials for control subjects, and even more for the sound limb of expert amputees. In contrast, plane rotation is very weak or absent for the prosthetic limb. We suggest that these results reveal a centrally commanded compensation strategy.


Subject(s)
Acceleration , Amputation, Surgical/rehabilitation , Artificial Limbs , Gait/physiology , Monitoring, Physiologic/instrumentation , Psychomotor Performance/physiology , Adaptation, Physiological , Adult , Amputation, Surgical/methods , Amputees/rehabilitation , Analysis of Variance , Biomechanical Phenomena , Case-Control Studies , Exercise Test/methods , Femur/surgery , Foot/physiology , Hip Joint/physiology , Humans , Leg , Male , Muscle, Skeletal/physiology , Prosthesis Fitting , Reference Values
3.
Neural Plast ; 2012: 375148, 2012.
Article in English | MEDLINE | ID: mdl-22272380

ABSTRACT

Success in locomotor rehabilitation programs can be improved with the use of brain-computer interfaces (BCIs). Although a wealth of research has demonstrated that locomotion is largely controlled by spinal mechanisms, the brain is of utmost importance in monitoring locomotor patterns and therefore contains information regarding central pattern generation functioning. In addition, there is also a tight coordination between the upper and lower limbs, which can also be useful in controlling locomotion. The current paper critically investigates different approaches that are applicable to this field: the use of electroencephalogram (EEG), upper limb electromyogram (EMG), or a hybrid of the two neurophysiological signals to control assistive exoskeletons used in locomotion based on programmable central pattern generators (PCPGs) or dynamic recurrent neural networks (DRNNs). Plantar surface tactile stimulation devices combined with virtual reality may provide the sensation of walking while in a supine position for use of training brain signals generated during locomotion. These methods may exploit mechanisms of brain plasticity and assist in the neurorehabilitation of gait in a variety of clinical conditions, including stroke, spinal trauma, multiple sclerosis, and cerebral palsy.


Subject(s)
Gait Disorders, Neurologic/physiopathology , Gait Disorders, Neurologic/rehabilitation , Prosthesis Design/methods , Spinal Cord/physiology , Humans , Models, Neurological , Nerve Net/physiology , Prosthesis Design/trends , Spinal Cord/cytology , User-Computer Interface
4.
Clin Neurophysiol ; 121(5): 754-65, 2010 May.
Article in English | MEDLINE | ID: mdl-20075001

ABSTRACT

OBJECTIVE: To address the question of how the CNS generates muscle activation patterns for complex gestures, we have chosen to study a figure-eight movement. We hypothesized that the well defined rhythmic aspect of this figure will provide further insights into the temporal features of multi-muscular commands. METHODS: Subjects performed, as fast as possible, figure-eights initiated in the center of the figure with 4 different initial directions and 2 positions of the shoulder. We extracted the temporal modulation of the EMG patterns by calculating conjugate cross-correlation functions. RESULTS: (1) The muscular command was tuned with respect to the rotational direction of the figure-eight, (2) two sets of synergistic muscles acted in a reciprocal mode, and (3) these reciprocal commands presented an invariant temporal correlation with the spatial component of the velocity having the highest frequency. CONCLUSION: Our results suggest that the rhythmic features of certain drawing movements favor the partitioning of the muscles into synergistic groups acting in a reciprocal mode. The inclusion of an individual muscle in one group or the other takes into account the expected number of changes of direction in the movement as a whole. SIGNIFICANCE: Muscular temporal synergies may depend on the rhythmic features of the trajectory.


Subject(s)
Central Nervous System/physiology , Movement/physiology , Muscle, Skeletal/physiology , Periodicity , Adult , Electromyography , Humans , Time Factors , Young Adult
5.
Brain Res ; 1121(1): 104-16, 2006 Nov 22.
Article in English | MEDLINE | ID: mdl-17034767

ABSTRACT

Electroencephalographic oscillations at 10 Hz (alpha and mu rhythms) are the most prominent rhythms observed in awake, relaxed (eye-closed) subjects. These oscillations may be considered as a marker of cortical inactivity or an index of the active inhibition of the sensory information. Different cortical sources may participate in the 10-Hz oscillation and appear to be modulated by the sensory context and functional demands. In microgravity, the marked reduction in multimodal graviceptive inputs to cortical networks participating in the representation of space could be expected to affect the 10-Hz activity. The effect of microgravity on this basic oscillation has heretofore not been studied quantitatively. Because the alpha rhythm has a functional role in the regulation of network properties of the visual areas, we hypothesised that the absence of gravity would affect its strength. Here, we report the results of an experiment conducted over the course of 3 space flights, in which we quantified the power of the 10-Hz activity in relation to the arrest reaction (i.e., in 2 distinct physiological states: eyes open and eyes closed). We observed that the power of the spontaneous 10-Hz oscillation recorded in the eyes-closed state in the parieto-occipital (alpha rhythm) and sensorimotor areas (mu rhythm) increased in the absence of gravity. The suppression coefficient during the arrest reaction and the related spectral perturbations produced by eye-opening/closure state transition also increased in on orbit. These results are discussed in terms of current theories on the source and the importance of the alpha rhythm for cognitive function.


Subject(s)
Cerebral Cortex/physiology , Electroencephalography , Gravitation , Weightlessness , Adult , Earth, Planet , Humans , Male , Oscillometry , Space Flight , Touch
6.
Eur J Neurosci ; 22(4): 861-70, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16115209

ABSTRACT

Calbindin is a fast Ca2+-binding protein expressed by Purkinje cells and involved in their firing regulation. Its deletion produced approximately 160-Hz oscillation sustained by synchronous, rhythmic Purkinje cells in the cerebellar cortex of mice. Parvalbumin is a slow-onset Ca2+-binding protein expressed in Purkinje cells and interneurons. In order to assess its function in Purkinje cell firing regulation, we studied the firing behavior of Purkinje cells in alert mice lacking parvalbumin (PV-/-), calbindin (CB-/-) or both (PV-/- CB-/-) and in wild-type controls. The absence of either protein resulted in Purkinje cell firing alterations (decreased complex spike duration and pause, increased simple spike firing rate) that were more pronounced in CB-/- than in PV-/- mice. Cumulative effects were found in complex spike alterations in PV-/- CB-/- mice. PV-/- and CB-/- mice manifested approximately 160-Hz oscillation that was sustained by Purkinje cells firing rhythmically and synchronously along the parallel fiber axis. This oscillation was dependent on GABA(A), N-methyl-D-aspartate and gap junction transmission. PV-/- CB-/- mice exhibited a dual-frequency (110 and 240 Hz) oscillation. The instantaneous spectral densities of both components were inversely correlated. Simple and complex spikes of Purkinje cells were phase-locked to one of the two oscillation frequencies. Mono- and dual-frequency oscillations presented similar pharmacological properties. These results demonstrate that the absence of the Ca2+ buffers parvalbumin and calbindin disrupts the regulation of Purkinje cell firing rate and rhythmicity in vivo and suggest that precise Ca2+ transient control is required to maintain the normal spontaneous arrhythmic and asynchronous firing pattern of the Purkinje cells.


Subject(s)
Action Potentials/physiology , Cerebellum/cytology , Parvalbumins/deficiency , Periodicity , Purkinje Cells/physiology , S100 Calcium Binding Protein G/genetics , 2-Amino-5-phosphonovalerate/pharmacology , Action Potentials/drug effects , Action Potentials/radiation effects , Analysis of Variance , Animals , Calbindin 2 , Calbindins , Carbenoxolone/pharmacology , Evoked Potentials/drug effects , Evoked Potentials/physiology , Evoked Potentials/radiation effects , Excitatory Amino Acid Antagonists/pharmacology , Fourier Analysis , GABA Antagonists/pharmacology , Immunohistochemistry/methods , Mice , Mice, Inbred C57BL , Mice, Knockout , Neural Inhibition/drug effects , Neural Inhibition/physiology , Neural Inhibition/radiation effects , Pyridazines/pharmacology , S100 Calcium Binding Protein G/metabolism , Time Factors
7.
Eur J Nucl Med ; 25(10): 1368-76, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9818275

ABSTRACT

In view of the EURATOM 96/29 [1] regulations, a prospective multicentre study was performed to evaluate the present guidelines given to relatives of patients treated with iodine-131 for both thyroid carcinoma and thyrotoxicosis, based on the real-life radiation burden. This study comprised 166 measurements carried out on a group of 94 relatives of 65 patients. All relatives wore a thermoluminescent dosemeter (TLD) on the wrist for 7 days. Sixty-one relatives agreed to wear another TLD for an additional 7 days. TLD were placed on nine patients' bedside tables. The eight participating centres were arbitrarily divided into three groups according to the period of time they advised their patients to sleep separately. Groups I, II and III respectively advised their patients to sleep separately for 0, 7-10 and 14-21 days. The median dose received by in-living relatives of thyroid carcinoma patients during the 14 days following hospital discharge was 281 microSv (doses to infinity not calculated); the median dose to infinity received by in-living relatives of ambulatory treated thyrotoxicosis patients was 596 microSv, as compared with 802 microSv for in-living relatives of hospitalised thyrotoxicosis patients. In general the children of patients received a significantly (P < 0.1) lower mean dose than their partners. For thyroid carcinoma patients, only two relatives out of 19 (10%) exceeded the EURATOM 96/29 limit of 1 mSv/year. For thyrotoxic patients, 28% of relatives exceeded the EURATOM 96/29 limit, but none of them were relatives of patients who followed guidelines for 21 days. The results of this study indicate that sleeping separately for 7 days, after a period of hospitalisation of 2-3 days, will usually be sufficient for thyroid carcinoma patients. For thyrotoxicosis patients, up to 21 days of sleeping separately could be necessary in order to strictly abide by EURATOM 96/29. Therefore, the authors propose the implementation of a non-rigid dose constraint for people who "knowingly and willingly" help patients treated with 131I, while still following the ALARA principle.


Subject(s)
Iodine Radioisotopes/analysis , Adolescent , Adult , Aged , Aged, 80 and over , Body Burden , Child , Child, Preschool , Family , Female , Humans , Infant , Iodine Radioisotopes/therapeutic use , Male , Middle Aged , Thermoluminescent Dosimetry , Thyroid Neoplasms/radiotherapy , Thyrotoxicosis/radiotherapy
SELECTION OF CITATIONS
SEARCH DETAIL